Trifluoromethyl-containing 3-spiroindoline derivative and preparation method thereof
By conducting free radical cyclization reaction with indole derivatives under visible light and photocatalyst, trifluoromethyl groups are directly introduced, which solves the failure to synthesize trifluoromethyl spirocyclic indoline derivatives in the prior art. The problem of this paper realizes an efficient and green synthesis method, with the characteristics of mild conditions and high purity products.
Patent Information
- Application Number
- CN202411113634.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art has failed to effectively synthesize spiro[indoline-3,3'-quinoline] and spiro[indoline-3,3'-pyrrole] compounds containing trifluoromethyl, lacking the direct introduction of trifluoromethyl The method of the base limits its application in organic compounds.
Free use of CF3Br with 3-(2-isocyanobenzyl)-1H-indole derivative or 3-(2-isocyanoethyl)-1H-indole derivative in the presence of visible light and photocatalysts The group tandem cyclization reaction directly introduces trifluoromethyl to form spiro[indoline-3,3'-quinoline] and spiro[indoline-3,3'-pyrrole] compounds containing trifluoromethyl groups .
It has achieved efficient, green and safe introduction of trifluoromethyl into spirocyclic indoline derivatives. It has the characteristics of mild reaction conditions, cheap and easy-to-access raw materials, high atomic economy, and high product purity, and is suitable for green synthesis.
Smart Images

Figure CN118994157A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of organic synthesis, and in particular relates to a 3-spiro indoline derivative containing a trifluoromethyl group and a preparation method thereof. Background Art
[0002] 3-Spiroindoline is an important class of heterocyclic compounds, and its structural units often exist in some natural products, drugs and bioactive molecules. Due to its good biological activity and potential therapeutic ability, it has attracted the attention of many organic chemists and biologists in recent years. For example, compounds with the following chemical structures A to F:
[0003]
[0004] Studies have shown that compound A, Helicobacter pylori type B, is a Clostridium lysine KMC003 isolated from acidic coal mine drainage, which has inhibitory activity against nitric oxide and reactive oxygen species (Org. Lett. 2012, 14, 5002); compound B, kelpine, is an alkaloid obtained from kelp, which has high anti-tumor activity (J. Am. Chem. Soc. 1981, 103, 4634); compound C, rauwolfia pine, is extracted from coffee beans and has the effects of stimulating the nervous system, dilating blood vessels and diuresis (J. Chem. Soc., 1960, 1394); compound D, baicalin, is a marine alkaloid isolated from the bryozoan papyrus fungus, which has antibacterial activity (Tetrahedron Lett.007,48,6364); Compound E, huperzine, a new monoterpene indole alkaloid isolated from the genus Huperzine in Malaysia, whose chemical activity has not yet been demonstrated (J.Am.Chem.Soc.2019,141,7147); Compound F, huperzine A, a polycyclic compound isolated from the tree of the lamp, is a traditional Chinese medicine used to treat various respiratory diseases (J.Am.Chem.Soc.2013,135,12964). In order to further expand the new method of synthesizing this skeleton and explore the potential application value of 3-spiro indoline derivatives, it will be very necessary to synthesize various functionalized spiro indoline derivatives.
[0005] At present, the methods for synthesizing 3-spirocyclic indoline derivatives include Fischer indoleation reaction, condensation reaction and cyclodearomatization reaction of indole derivatives (Chem. Eur. J. 2015, 22, 2856). The synthesis routes of the three methods are:
[0006]
[0007] In recent years, various functionalized 3-spiro indole derivatives can be rapidly constructed through the free radical addition cyclodearomatization reaction of indole derivatives. Among them, 3-(2-isocyanobenzyl)-1H-indole derivatives and 3-(2-isocyanoethyl)-1H-indole derivatives can generate various functionalized spiro[indoline-3,3'-quinoline] compounds and spiro[indoline-3,3'-pyrrole] compounds through free radical isonitrile insertion cyclodearomatization reaction.
[0008] The specific method is as follows:
[0009] (1) Radical isonitrile insertion cyclodearomatization reaction of 3-(2-isocyanobenzyl)-1H-indole derivatives;
[0010] In 2020, Wang Qingming's research group proposed the use of photocatalytic redox strategy (Chem. Commun. 2020, 56, 15212), starting from 3-(2-isocyanobenzyl)-1H-indole derivatives, with the assistance of photocatalyst fac-Ir(ppy)3 and base NaHCO3, DMSO as solvent, to synthesize difluoromethyl-containing spiro[indoline-3,3'-quinoline] compounds at room temperature. This method is simple and efficient to synthesize 3-spirocyclic indoline compounds containing difluoromethyl groups, and its reaction formula is:
[0011]
[0012] In 2022, Xu Yanli's research group reported a free radical tandem cyclization dearomatization reaction of 3-(2-isocyanobenzyl)-1H-indole derivatives under visible light catalysis (Chin.J.Org.Chem.2022,42,2867). This method uses tert-butyl hydroperoxide (TBHP) as an oxidant and acetonitrile as a solvent, and reacts under nitrogen protection to obtain tin-based spiro[indoline-3,3'-quinoline] compounds. This method uses stoichiometric peroxide as an oxidant, but peroxide is unstable and poses a safety hazard. The reaction formula is:
[0013]
[0014] (2) Radical isonitrile insertion cyclodearomatization of 3-(2-isocyanoethyl)-1H-indole derivatives;
[0015] In 2023, Ji Shunjun's research group proposed a radical tandem cyclization dearomatization reaction of an organic boronic acid reagent oxidized by Mn(acac)3 and a 3-(2-isocyanoethyl)-1H-indole derivative to obtain a functionalized spiro[indoline-3,3'-pyrrole] compound (Org.Chem.Front., 2023, 10, 1660). The advantage of this method is that the substrate has a wide range of applicability and realizes the construction of complex molecules. The disadvantage is that peroxide is used as an oxidant and is carried out under high temperature conditions. The reaction conditions are harsh and not conducive to industrial production. The reaction formula is:
[0016]
[0017] In 2024, Orru's research group developed a free radical tandem cyclization dearomatization reaction of 3-(2-isocyanoethyl)-1H-indole derivatives and α-bromocarbonyl compounds under visible light catalysis (Chem. Sci., 2024, 15, 6867). The reaction was carried out under 265nm light source irradiation conditions, 2.0equiv 2,6-dimethylpyridine (2,6-lutidine) as a base, in toluene solvent, and a series of spiro[indoline-3,3'-pyrrole] compounds were obtained at 30-37°C. The disadvantage of this reaction is that toxic toluene is used as a solvent and twice the stoichiometric amount of base is used. The reaction formula is:
[0018]
[0019] In summary, people have synthesized various functionalized spiro[indoline-3,3'-quinoline] and spiro[indoline-3,3'-pyrrole] compounds from 3-(2-isocyanobenzyl)-1H-indole derivatives and 3-(2-isocyanoethyl)-1H-indole derivatives through free radical tandem cyclodearomatization reaction strategies, but each method has its own defects and limitations. Trifluoromethyl is a common fluorinated group. The introduction of trifluoromethyl into organic compounds can significantly change the chemical, physical and biological properties of the parent compound, such as acidity, bioavailability, metabolic stability, lipid solubility and protein binding ability. However, there is no report on the synthetic method of directly introducing trifluoromethyl into spiro[indoline-3,3'-quinoline] and spiro[indoline-3,3'-pyrrole] rings in the prior art. Therefore, it is very necessary to explore a new, efficient and simple synthetic method to prepare trifluoromethyl-containing spiro[indoline-3,3'-quinoline] compounds and spiro[indoline-3,3'-pyrrole] compounds. Summary of the invention
[0020] In order to solve the above technical problems, the present invention provides a 3-spiro indoline derivative containing a trifluoromethyl group and a preparation method thereof.
[0021] To achieve the above object, the present invention provides the following technical solutions:
[0022] The present invention provides a 3-spiro indoline derivative containing a trifluoromethyl group, which is a spiro[indoline-3,3'-quinoline] compound containing a trifluoromethyl group, and the general structural formula is shown in Formula 3; or a spiro[indoline-3,3'-pyrrole] compound containing a trifluoromethyl group, and the general structural formula is shown in Formula 5:
[0023]
[0024] In the formula, R 1 H or Me, R 2 is H or Cl, R 3 It is H or Me.
[0025] The present invention also provides a method for preparing the 3-spiro indoline derivative containing a trifluoromethyl group described in the above technical scheme, comprising the following steps: in the presence of visible light, a photocatalyst and a base, CF3Br and a 3-(2-isocyanobenzyl)-1H-indole derivative or a 3-(2-isocyanoethyl)-1H-indole derivative are subjected to a free radical tandem cyclization reaction in an organic solvent to obtain the 3-spiro indoline derivative containing a trifluoromethyl group.
[0026] Preferably, the CF3Br is added in the form of CF3Br gas; the pressure of the CF3Br gas is 1.0 atm, and the added amount is excessive.
[0027] Preferably, the structural formulas of the 3-(2-isocyanobenzyl)-1H-indole derivative 1 and the 3-(2-isocyanoethyl)-1H-indole derivative 4 are:
[0028]
[0029] In the formula, R 1 H or Me, R 2 is H or Cl, R 3 It is H or Me.
[0030] Preferably, the photocatalyst includes a noble metal catalyst or an organic dye catalyst; the amount of the photocatalyst used is 0.5 to 2.0 mol% of the amount of 3-(2-isocyanobenzyl)-1H-indole derivative or 3-(2-isocyanoethyl)-1H-indole derivative, and more preferably 1.0 mol%.
[0031] Preferably, the noble metal catalyst is one or more of tris[2-(2-pyridyl)phenyl]iridium (fac-Ir(ppy)3) and terpyridyl ruthenium chloride (Ru(bpy)3Cl2); the organic dye catalyst is one or more of 2,4,5,6-tetrakis(9-carbazolyl)-isophthalonitrile (4CzIPN) and 2,4,6-tris(diphenylamino)-3,5-difluorobenzonitrile (3DPA2FBN), and more preferably 2,4,6-tris(diphenylamino)-3,5-difluorobenzonitrile (3DPA2FBN). The present invention uses the organic dye 3DPA2FBN as a photocatalyst to catalyze CF3Br to produce trifluoromethyl radicals under the induction of clean energy visible light, which is green, efficient and sustainable.
[0032] Preferably, the molar ratio of the 3-(2-isocyanobenzyl)-1H-indole derivative or 3-(2-isocyanoethyl)-1H-indole derivative to the base is 1:(0.5-1.5), more preferably 1:1.
[0033] Preferably, the base includes an inorganic base or an organic base; the inorganic base includes any one of potassium carbonate (K2CO3), sodium carbonate (Na2CO3) and potassium bicarbonate (KHCO3), and the organic base includes any one of 1,8-diazabicyclo[5,4,0]undecene-7 (DBU) and 1,4-diazabicyclo[2.2.2]octane (DABCO).
[0034] Preferably, the visible light is blue light with a wavelength of 390 to 460 nm and a power of 5 to 20 W, more preferably 10 W blue light.
[0035] Preferably, the organic solvent includes any one of dichloromethane (DCM), acetonitrile (CH3CN), dimethyl sulfoxide (DMSO), N,N-dimethylformamide (DMF) and tetrahydrofuran (THF), and more preferably N,N-dimethylformamide (DMF).
[0036] More preferably, the amount of the organic solvent used is 1 to 3 mL.
[0037] Preferably, the free radical tandem cyclization reaction time is 12 to 48 hours, and the free radical tandem cyclization reaction temperature is room temperature.
[0038] More preferably, the free radical tandem cyclization reaction further includes extraction, drying and purification; the extraction agent includes ethyl acetate; the drying desiccant includes anhydrous Na2SO4; the purification method is column chromatography; the column chromatography uses silica gel as the stationary phase and petroleum ether and ethyl acetate as eluents; the volume ratio of petroleum ether to ethyl acetate is (4-6):1.
[0039] Compared with the prior art, the present invention has the following advantages and technical effects:
[0040] (1) The present invention introduces trifluoromethyl into spiro[indoline-3,3'-quinoline] compounds and spiro[indoline-3,3'-pyrrole] compounds for the first time, and uses 3-(2-isocyanobenzyl)-1H-indole derivatives and 3-(2-isocyanoethyl)-1H-indole derivatives as raw materials, CF3Br as a fluorination agent, and under the induction of visible light and the action of photocatalysts and bases, a free radical tandem cyclization dearomatization reaction is used to prepare spiro[indoline-3,3'-quinoline] compounds and spiro[indoline-3,3'-pyrrole] compounds containing trifluoromethyl in one step. The present invention directly introduces trifluoromethyl groups into spiro[indoline-3,3'-quinoline] and spiro[indoline-3,3'-pyrrole] rings for the first time, and has the characteristics of being green and safe, cheap and readily available raw materials, high atom economy, mild reaction conditions, a wide range of substrate applications, and easy purification of products, and belongs to green synthesis.
[0041] (2) The present invention is the first to use CF3Br for a radical tandem cyclodearomatization reaction involving 3-(2-isocyanobenzyl)-1H-indole derivatives and 3-(2-isocyanoethyl)-1H-indole derivatives to construct trifluoromethyl-substituted spiro[indoline-3,3'-quinoline] compounds and spiro[indoline-3,3'-pyrrole] compounds. CF3Br is a non-toxic, odorless, cheap and readily available industrial raw material. Compared with other fluorination agents, its greatest advantages are low price, easy availability and high atom economy.
[0042] (3) The synthesis method provided by the present invention has the characteristics of short reaction steps, high atomic utilization rate, simple operation, mild reaction conditions and high yield.
[0043] (4) The spiro[indoline-3,3'-quinoline] compounds and spiro[indoline-3,3'-pyrrole] compounds synthesized by the present invention are 1 H NMR, 13 C NMR, 19 F NMR and high-resolution mass spectrometry detection showed that the obtained product was a pure target compound with high purity. BRIEF DESCRIPTION OF THE DRAWINGS
[0044] The drawings constituting a part of the present application are used to provide a further understanding of the present application. The illustrative embodiments and descriptions of the present application are used to explain the present application and do not constitute an improper limitation on the present application. In the drawings:
[0045] Figure 1 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) prepared in Example 11 H NMR spectra;
[0046] Figure 2 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) prepared in Example 1 13 C NMR spectra;
[0047] Figure 3 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) prepared in Example 1 19 F NMR spectra;
[0048] Figure 4 This is a high-resolution mass spectrometry monitoring diagram of 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) prepared in Example 1;
[0049] Figure 5 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3b) prepared in Example 2 1 H NMR spectra;
[0050] Figure 6 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3b) prepared in Example 2 13 C NMR spectra;
[0051] Figure 7 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3b) prepared in Example 2 19 F NMR spectra;
[0052] Figure 8 This is a high-resolution mass spectrometry monitoring diagram of 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3b) prepared in Example 2;
[0053] Fig. 9 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3c) prepared in Example 3 1 H NMR spectra;
[0054] Fig.10 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3c) prepared in Example 3 13 C NMR spectra;
[0055] Fig.11 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3c) prepared in Example 3 19 F NMR spectra;
[0056] Fig.12 This is a high-resolution mass spectrometry monitoring diagram of 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3c) prepared in Example 3;
[0057] Fig.13 2-methyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3d) prepared in Example 4 1 H NMR spectra;
[0058] Fig.14 2-methyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3d) prepared in Example 4 13 C NMR spectra;
[0059] Fig.15 2-methyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3d) prepared in Example 4 19 F NMR spectra;
[0060] Fig.16 This is a high-resolution mass spectrometry monitoring diagram of 2-methyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3d) prepared in Example 4;
[0061] Fig.17 2,5-dimethyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3e) prepared in Example 5 1 H NMR spectra;
[0062] Fig.18 2,5-dimethyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3e) prepared in Example 5 13 C NMR spectra;
[0063] Fig.19 2,5-dimethyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3e) prepared in Example 5 19 F NMR spectra;
[0064] Fig. 20This is a high-resolution mass spectrum monitoring chart of 2,5-dimethyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3e) prepared in Example 5. DETAILED DESCRIPTION
[0065] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0066] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the present invention is further described in detail below with reference to the accompanying drawings and specific embodiments.
[0067] The room temperature in the embodiments of the present invention refers to "25±2°C".
[0068] Unless otherwise specified, the raw materials in the examples of the present invention were purchased from commercial sources.
[0069] Example 1
[0070] A method for preparing 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a), wherein the synthetic route is:
[0071]
[0072] 3-(2-isocyanobenzyl)-2-methyl-1H-indole (49 mg, 0.2 mmol, 1.0 equiv), 3DPA2FBN (1.28 mg, 1.0 mol%), K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv), and 2 mL of DMF were added to a 50 mL Schlenk flask. The Schlenk flask was evacuated to vacuum and then filled with CF3Br gas, and this was repeated three times. Finally, the pressure in the Schlenk flask was maintained at 1.0 atm (observed from the barometer). The reaction mixture was placed under 10 W blue light and stirred at room temperature for 24 h. After the reaction, the reaction mixture was diluted with water (5 mL), extracted with ethyl acetate (3 mL×3), the organic phases were combined, washed with saturated brine (10 mL×3), separated, dried over anhydrous Na2SO4, and concentrated using a rotary evaporator. The remaining residue was purified by column chromatography using silica gel as the stationary phase and petroleum ether and ethyl acetate as eluents (PE:EA=4:1, volume ratio) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline](3a) as a yellow solid, 52.2 mg, with a yield of 83%.
[0073] The 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) synthesized in Example 1 was 1 HNMR, 13 CNMR, 19 FNMR and high-resolution mass spectrometry detection, the results are shown in Figure 1-4 ,from Figure 1-4 It can be concluded that the product obtained in Example 1 is a pure target compound.
[0074] The characterization data of the product are:
[0075] 1 H NMR (400MHz, CDCl3) δ7.66(d,J=7.6Hz,1H),7.59(d,J=7.6Hz,1H),7.45(t,J=7.6Hz,1H),7.41-7.34(m,2 H),7.17-7.12(m,2H),7.04(d,J=7.2Hz,1H),3.16(d,J=16.4Hz,1H),3.07(d,J=16.8Hz,1H),2.22(s,3H).
[0076] 13 C{ 1 H}NMR(150MHz,CDCl3)δ179.1,154.8,154.1(q,J C-F=34.5Hz),140.7,138.8,130.4,129.4,129.0,128.7,128.1,126.1,125.2,122.6,120.7,119.7(q,J C-F =277.5Hz),58.7,34.2,17.5.
[0077] 19 F NMR (376MHz, CDCl3) δ-68.77.
[0078] HRMS (ESI)calcd or C 18 H 14 N2F3[M+H] + 315.1104, found 315.1105.
[0079] Example 2
[0080] A method for preparing 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3b), wherein the synthetic route is:
[0081]
[0082] 3-(2-isocyano-5-methylbenzyl)-2-methyl-1H-indole (52 mg, 0.2 mmol, 1.0 equiv), 3DPA2FBN (1.28 mg, 1.0 mol%), K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv), and 2 mL of DMF were added to a 50 mL Schlenk flask. The Schlenk flask was evacuated and then filled with CF3Br gas, which was repeated three times. Finally, the pressure in the Schlenk flask was maintained at 1.0 atm (observed from the barometer). The reaction mixture was placed under 10 W blue light and stirred at room temperature for 24 h. After the reaction, the reaction mixture was diluted with water (5 mL), extracted with ethyl acetate (3 mL×3), the organic phases were combined, washed with saturated brine (10 mL×3), separated, dried over anhydrous Na2SO4, and concentrated using a rotary evaporator. The remaining residue was purified by column chromatography using silica gel as the stationary phase and petroleum ether and ethyl acetate as eluents (PE:EA=4:1, volume ratio) to obtain 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3b) as a yellow oily liquid, 52.5 mg, with a yield of 80%.
[0083] 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3b) synthesized in Example 2 was reacted with 1HNMR, 13 CNMR, 19 FNMR and high-resolution mass spectrometry detection, the results are shown in Figure 5-8 ,from Figure 5-8 It can be concluded that the product obtained in Example 2 is a pure target compound.
[0084] The characterization data of the product are:
[0085] 1 H NMR (400MHz, CDCl3) δ7.53-7.43(m,2H),7.29(d,J=8.0Hz,1H),7.38(t,J=8.4Hz,1H),7.05(d,J=10.4Hz,1H), 6.95(d,J=9.6Hz,1H),6,86(m,1H),3.03(d,J=16.8Hz,1H),2.91(d,J=16.8Hz,1H),2.29(s,3H),2.13(s,3H).
[0086] 13 C{ 1 H}NMR(150MHz,CDCl3)δ179.3,154.7,152.6(q,J C-F =33.0Hz),140.9,139.0,138.5,129.3,129.2,128.8,128.8,125.9,124.9,122.6,120.5,119.8(q,J C-F =276.0Hz),58.7,34.2,21.4,17.2.
[0087] 19 F NMR (376MHz, CDCl3) δ-68.62.
[0088] HRMS (ESI)calcd or C 19 H 16 N2F3[M+H] + 329.1260, found 329.1267.
[0089] Example 3
[0090] A method for preparing 5-chloro-2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3c), wherein the synthetic route is:
[0091]
[0092] 5-Chloro-3-(2-isocyanobenzyl)-2-methyl-1H-indole (56.2 mg, 0.2 mmol, 1.0 equiv), 3DPA2FBN (1.28 mg, 1.0 mol%), K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv), and 2 mL of DMF were added to a 50 mL Schlenk flask. The Schlenk flask was evacuated and then filled with CF3Br gas, and this was repeated three times. Finally, the pressure in the Schlenk flask was maintained at 1.0 atm (observed from the barometer). The reaction mixture was placed under 10 W blue light and stirred at room temperature for 24 h. After the reaction, the reaction mixture was diluted with water (5 mL), extracted with ethyl acetate (3 mL×3), the organic phases were combined, washed with saturated brine (10 mL×3), separated, dried over anhydrous Na2SO4, and concentrated using a rotary evaporator. The remaining residue was purified by column chromatography using silica gel as the stationary phase and petroleum ether and ethyl acetate as eluents (PE:EA=6:1, volume ratio) to obtain 2,6'-dimethyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3c) as a yellow oily liquid, 60.0 mg, with a yield of 86%.
[0093] 5-Chloro-2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3c) synthesized in Example 3 was reacted with 1 HNMR, 13 CNMR, 19 FNMR and high-resolution mass spectrometry detection, the results are shown in Figure 9-12 ,from Figure 9-12 It can be concluded that the product obtained in Example 3 is a pure target compound.
[0094] The characterization data of the product are:
[0095] 1 H NMR (400MHz, CDCl3) δ7.67(d,J=7.6Hz,1H),7.50(d,J=8.4,1H),7.46(t,J=8.4Hz,1H),7.40-7.35(m,2H), 7.17(d,J=7.2Hz,1H), 7.01(d,J=2.0Hz,1H), 3.16(d,J=16.4Hz,1H), 3.07(d,J=16.8Hz,1H), 2.20(s,3H).
[0096] 13 C{ 1 H}NMR(150MHz,CDCl3)δ179.7,153.4,153.1(q,J C-F=33.0Hz),140.5,140.4,131.8,130.7,129.7,129.1,129.0,128.1,124.6,123.1,121.5,119.6(q,J C-F =276.0Hz),59.0,34.0,17.5.
[0097] 19 F NMR (376MHz, CDCl3) δ-68.71.
[0098] HRMS (ESI)calcd or C 18 H 13 N2F3Cl[M+H] + 349.0714, found 349.0714.
[0099] Example 4
[0100] A method for preparing 2-methyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole](3d), wherein the synthetic route is:
[0101]
[0102] 3-(2-isocyanoethyl)-2-methyl-1H-indole (36.8 mg, 0.2 mmol, 1.0 equiv), 3DPA2FBN (1.28 mg, 1.0 mol%), K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv), and 2 mL of DMF were added to a 50 mL Schlenk flask. The Schlenk flask was evacuated and then filled with CF3Br gas, and this process was repeated three times. Finally, the pressure in the Schlenk flask was maintained at 1.0 atm (observed from the barometer). The reaction mixture was placed under 10 W blue light and stirred at room temperature for 24 h. After the reaction, the reaction mixture was diluted with water (5 mL), extracted with ethyl acetate (3 mL×3), the organic phases were combined, washed with saturated brine (10 mL×3), separated, dried over anhydrous Na2SO4, and concentrated using a rotary evaporator. The remaining residue was purified by column chromatography using silica gel as the stationary phase and petroleum ether and ethyl acetate as eluents (PE:EA=4:1, volume ratio) to obtain 2-methyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3d) as a yellow oily liquid, 34.3 mg, with a yield of 68%.
[0103] The 2-methyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3d) synthesized in Example 4 was reacted with 1HNMR, 13 CNMR, 19 FNMR and high-resolution mass spectrometry detection, the results are shown in Figure 13-16 ,from Figure 13-16 It can be concluded that the product obtained in Example 4 is a pure target compound.
[0104] The characterization data of the product are:
[0105] 1 H NMR (400MHz, CDCl3) δ7.58 (d, J = 7.6Hz, 1H), 7.42-7.38 (m, 1H), 7.28-7.24 (m ,2H),4.57-4.38(m,2H),2.60-2.53(m,1H),2.50-2.40(m,1H),2.30(s,3H).
[0106] 13 C{ 1 H}NMR(150MHz,CDCl3)δ178.4,164.5(q,J C-F =34.5Hz),155.1,139.0,129.2,126.2,122.0,120.5,118.9(q,J C-F =275.6Hz),72.2,60.9,34.4,16.3.
[0107] 19 F NMR (376MHz, CDCl3) δ-67.16.
[0108] HRMS (ESI)calcd or C 13 H 12 N2F3[M+H] + 253.0947, found 253.0937.
[0109] Example 5
[0110] A method for preparing 2,5-dimethyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole](3e), wherein the synthetic route is:
[0111]
[0112] 3-(2-isocyanoethyl)-2,5-dimethyl-1H-indole (37.8 mg, 0.2 mmol, 1.0 equiv), 3DPA2FBN (1.28 mg, 1.0 mol%), K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv), and 2 mL of DMF were added to a 50 mL Schlenk flask. The Schlenk flask was evacuated and then filled with CF3Br gas, and this process was repeated three times. Finally, the pressure in the Schlenk flask was maintained at 1.0 atm (observed from the barometer). The reaction mixture was placed under 10 W blue light and stirred at room temperature for 24 h. After the reaction, the reaction mixture was diluted with water (5 mL), extracted with ethyl acetate (3 mL×3), the organic phases were combined, washed with saturated brine (10 mL×3), separated, dried over anhydrous Na2SO4, and concentrated using a rotary evaporator. The remaining residue was purified by column chromatography using silica gel as the stationary phase and petroleum ether and ethyl acetate as eluents (PE:EA=4:1, volume ratio) to obtain 2,5-dimethyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3e) as a white solid, 41.5 mg, with a yield of 78%.
[0113] The 2,5-dimethyl-2'-(trifluoromethyl)-4',5'-dihydrospiro[indoline-3,3'-pyrrole] (3e) synthesized in Example 5 was reacted with 1 HNMR, 13 CNMR, 19 FNMR and high-resolution mass spectrometry detection, the results are shown in Figure 17-20 ,from Figure 17-20 It can be concluded that the product obtained in Example 5 is a pure target compound.
[0114] The characterization data of the product are:
[0115] 1 H NMR(400MHz, CDCl3) δ7.45(d,J=8.0Hz,1H),7.19(d,J=7.6Hz,1H),7.04(s, 1H),4.56-4.39(m,2H),2.59-2.52(m,1H),2.45-2.38(m,4H),2.28(s,3H).
[0116] 13 C{ 1 H}NMR(150MHz,CDCl3)δ177.3,164.7(q,J C-F =34.5Hz),153.0,139.2,136.2,129.8,122.7,120.0,119.0(q,J C-F=276.0Hz),72.1,60.9,34.6,21.3,16.2.
[0117] 19 F NMR (376MHz, CDCl3) δ-67.11.
[0118] HRMS (ESI)calcd or C 14 H 14 N2F3[M+H] + 267.1104, found 267.1106.
[0119] Example 6
[0120] The difference from Example 1 is that 3DPA2FBN (1.28 mg, 1.0 mol%) was replaced by fac-Ir(ppy)3 (1.31 mg, 1 mol%) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a), a yellow solid, 35.8 mg, with a yield of 57%.
[0121] Example 7
[0122] The difference from Example 1 is that 3DPA2FBN (1.28 mg, 1.0 mol%) was replaced by Ru(bpy)3Cl2 (1.86 mg, 1.0 mol%) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a), a yellow solid, 20.1 mg, with a yield of 32%.
[0123] Example 8
[0124] The difference from Example 1 is that 3DPA2FBN (1.28 mg, 1.0 mol%) was replaced by 4CzIPN (1.58 mg, 1.0 mol%) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a), a yellow solid, 42.1 mg, with a yield of 67%.
[0125] Example 9
[0126] The difference from Example 1 is that 3DPA2FBN (1.28 mg, 1.0 mol%) was replaced by 3DPA2FBN (0.64 mg, 0.5 mol%) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a), a yellow solid, 32.7 mg, with a yield of 52%.
[0127] Example 10
[0128] The difference from Example 1 is that 3DPA2FBN (1.28 mg, 1.0 mol%) was replaced by 3DPA2FBN (1.92 mg, 1.5 mol%) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a): yellow solid, 45.9 mg, yield 73%.
[0129] Embodiment 11
[0130] The difference from Example 1 is that 3DPA2FBN (1.28 mg, 1.0 mol%) was replaced by 3DPA2FBN (2.6 mg, 2.0 mol%) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a), a yellow solid, 42.1 mg, with a yield of 67%.
[0131] Example 12
[0132] The difference from Example 8 is that K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv) was replaced by Na2CO3 (21.2 mg, 0.2 mmol, 1.0 equiv) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 39.6 mg, with a yield of 63%.
[0133] Example 13
[0134] The difference from Example 8 is that K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv) was replaced by KHCO3 (20.0 mg, 0.2 mmol, 1.0 equiv) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 45.3 mg, with a yield of 72%.
[0135] Embodiment 14
[0136] The difference from Example 8 is that K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv) was replaced by DBU (30.4 mg, 0.2 mmol, 1.0 equiv) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 32.7 mg, with a yield of 52%.
[0137] Embodiment 15
[0138] The difference from Example 8 is that K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv) was replaced by DABCO (22.4 mg, 0.2 mmol, 1.0 equiv) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 30.8 mg, with a yield of 49%.
[0139] Example 16
[0140] The difference from Example 8 is that K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv) was replaced by K2CO3 (13.8 mg, 0.1 mmol, 0.5 equiv) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 27.6 mg, with a yield of 44%.
[0141] Embodiment 17
[0142] The difference from Example 8 is that K2CO3 (27.6 mg, 0.2 mmol, 1.0 equiv) was replaced by K2CO3 (41.5 mg, 0.3 mmol, 1.5 equiv) to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 43.4 mg, with a yield of 69%.
[0143] Embodiment 18
[0144] The difference from Example 15 is that DMF is replaced by DCM to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 22.0 mg, with a yield of 35%.
[0145] Embodiment 19
[0146] The difference from Example 15 is that DMF is replaced by CH3CN to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 29.5 mg, with a yield of 47%.
[0147] Embodiment 20
[0148] The difference from Example 15 is that DMF is replaced by THF to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 30.8 mg, with a yield of 27.7%.
[0149] Embodiment 21
[0150] The difference from Example 15 is that DMF is replaced by DMSO to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 49.0 mg, with a yield of 78%.
[0151] Embodiment 22
[0152] The difference from Example 15 was that 2 mL of DMF was replaced by 1 mL of DMF to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 41.5 mg, with a yield of 66%.
[0153] Embodiment 23
[0154] The difference from Example 15 was that 2 mL of DMF was replaced by 3 mL of DMF to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 45.3 mg, with a yield of 72%.
[0155] Embodiment 24
[0156] The difference from Example 23 is that 10 W blue light is replaced by 5 W blue light, to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a), a yellow solid, 34.6 mg, with a yield of 55%.
[0157] Embodiment 25
[0158] The difference from Example 23 is that 10 W blue light is replaced by 15 W blue light, to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a), a yellow solid, 47.8 mg, with a yield of 76%.
[0159] Embodiment 26
[0160] The difference from Example 23 is that 10 W blue light is replaced by 20 W blue light to obtain 2-methyl-2'-(trifluoromethyl)-4'H-spiro[indoline-3,3'-quinoline] (3a) as a yellow solid, 39.6 mg, with a yield of 63%.
[0161] The above are only preferred specific implementations of the present application, but the protection scope of the present application is not limited thereto. Any changes or substitutions that can be easily thought of by a person skilled in the art within the technical scope disclosed in the present application should be included in the protection scope of the present application. Therefore, the protection scope of the present application should be based on the protection scope of the claims.
Claims
1. A 3-spirocyclic indoline derivative containing a trifluoromethyl group, characterized in that: It is a spiro[indoline-3,3'-quinoline] compound containing a trifluoromethyl group, and the general structural formula is shown in Formula 3; or a spiro[indoline-3,3'-pyrrole] compound containing a trifluoromethyl group, and the general structural formula is shown in Formula 5: In the formula, R 1 H or Me, R 2 is H or Cl, R 3 It is H or Me.
2. A method for preparing the trifluoromethyl-containing 3-spiroindoline derivative according to claim 1, characterized in that: The following steps are included: In the presence of visible light, a photocatalyst and a base, CF3Br and a 3-(2-isocyanobenzyl)-1H-indole derivative or a 3-(2-isocyanoethyl)-1H-indole derivative are subjected to a free radical tandem cyclization reaction in an organic solvent to obtain the 3-spiro indoline derivative containing a trifluoromethyl group.
3. The preparation method according to claim 2, characterized in that: The CF3Br is added in the form of CF3Br gas; the pressure of the CF3Br gas is 1.0 atm, and the added amount is excessive.
4. The preparation method according to claim 2, characterized in that: The photocatalyst comprises a noble metal catalyst or an organic dye catalyst; the amount of the photocatalyst used is 0.5 to 2.0 mol% of the amount of the 3-(2-isocyanobenzyl)-1H-indole derivative or the 3-(2-isocyanoethyl)-1H-indole derivative.
5. The preparation method according to claim 4, characterized in that: The noble metal catalyst is one or more of tris[2-(2-pyridyl)phenyl]iridium and terpyridine ruthenium chloride, and the organic dye catalyst is one or more of 2,4,5,6-tetrakis(9-carbazolyl)-isophthalonitrile and 2,4,6-tris(diphenylamino)-3,5-difluorobenzonitrile.
6. The preparation method according to claim 2, characterized in that: The molar ratio of the 3-(2-isocyanobenzyl)-1H-indole derivative or 3-(2-isocyanoethyl)-1H-indole derivative to the base is 1:(0.5-1.5).
7. The preparation method according to claim 2 or 6, characterized in that: The base includes an inorganic base or an organic base; the inorganic base includes any one of potassium carbonate, sodium carbonate and potassium bicarbonate; the organic base includes any one of 1,8-diazabicyclo[5,4,0]undecene-7 and 1,4-diazabicyclo[2.2.2]octane.
8. The preparation method according to claim 2, characterized in that: The visible light is blue light with a wavelength of 390-460nm and a power of 5-20W.
9. The preparation method according to claim 2, characterized in that: The organic solvent includes any one of dichloromethane, acetonitrile, dimethyl sulfoxide, N,N-dimethylformamide and tetrahydrofuran.
10. The preparation method according to claim 2, characterized in that: The time of the free radical tandem cyclization reaction is 12 to 48 hours, and the temperature of the free radical tandem cyclization reaction is room temperature.
Citation Information
Patent Citations
Synthetic method of trifluoromethyl-containing spiro indoline or acetal
CN109232606A
Synthetic method of trifluoromethyl indole derivative
CN117430542A
Synthesis method of 3-trifluoromethyl chromone compound
CN118026978A
Cited By
3-trifluoromethyl tetrahydroquinoline compound and preparation method thereof
CN118812428A
A 3-trifluoromethyltetrahydroquinoline compound and its preparation method
CN118812428B
